[go: up one dir, main page]

DK1776109T3 - Farmaceutisk formulering omfattende et antibiotikum, en triazol og et cortocosteroid - Google Patents

Farmaceutisk formulering omfattende et antibiotikum, en triazol og et cortocosteroid

Info

Publication number
DK1776109T3
DK1776109T3 DK05786782T DK05786782T DK1776109T3 DK 1776109 T3 DK1776109 T3 DK 1776109T3 DK 05786782 T DK05786782 T DK 05786782T DK 05786782 T DK05786782 T DK 05786782T DK 1776109 T3 DK1776109 T3 DK 1776109T3
Authority
DK
Denmark
Prior art keywords
cortocosteroid
triazole
antibiotic
pharmaceutical formulation
formulation
Prior art date
Application number
DK05786782T
Other languages
Danish (da)
English (en)
Inventor
Abu Huq
Allan J Weingarten
Robert D Simmons
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Application granted granted Critical
Publication of DK1776109T3 publication Critical patent/DK1776109T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
DK05786782T 2004-08-13 2005-08-10 Farmaceutisk formulering omfattende et antibiotikum, en triazol og et cortocosteroid DK1776109T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60147504P 2004-08-13 2004-08-13
PCT/US2005/028379 WO2006020689A1 (en) 2004-08-13 2005-08-10 Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid

Publications (1)

Publication Number Publication Date
DK1776109T3 true DK1776109T3 (da) 2009-05-04

Family

ID=35431350

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05786782T DK1776109T3 (da) 2004-08-13 2005-08-10 Farmaceutisk formulering omfattende et antibiotikum, en triazol og et cortocosteroid

Country Status (27)

Country Link
US (2) US8084445B2 (es)
EP (1) EP1776109B1 (es)
JP (2) JP4792032B2 (es)
KR (1) KR101289115B1 (es)
CN (2) CN101039668A (es)
AR (1) AR050838A1 (es)
AT (1) ATE418984T1 (es)
AU (1) AU2005272925B2 (es)
BR (1) BRPI0514098B1 (es)
CA (1) CA2576589C (es)
DE (1) DE602005012107D1 (es)
DK (1) DK1776109T3 (es)
EC (1) ECSP077239A (es)
ES (1) ES2320360T3 (es)
IL (1) IL181248A (es)
MX (1) MX2007001811A (es)
MY (1) MY145148A (es)
NO (1) NO20073073L (es)
NZ (1) NZ553119A (es)
PE (1) PE20060489A1 (es)
PL (1) PL1776109T3 (es)
PT (1) PT1776109E (es)
RU (1) RU2394573C2 (es)
TW (1) TWI362261B (es)
UA (1) UA89793C2 (es)
WO (1) WO2006020689A1 (es)
ZA (1) ZA200701253B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2258980T3 (es) * 1999-08-16 2006-09-16 Revaax Pharmaceuticals Llc Composiciones farmaceuticas que comprenden acido clavulanico o derivados del mismo para el tratamiento de trastornos del comportamiento.
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
RU2394573C2 (ru) 2004-08-13 2010-07-20 Шеринг-Плоу Лтд. Фармацевтическая композиция
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
US20090275552A1 (en) * 2006-04-28 2009-11-05 Mahesh Vithalbhai Patel Therapy for Treating Resistant Bacterial Infections
WO2008002118A1 (es) * 2006-06-27 2008-01-03 Arturo Jimenez Bayardo Una formulación oftálmica en suspensión de etabonato de loteprednol y clorhidrato de ciprofloxacina
BRPI0703127A2 (pt) * 2007-08-22 2009-04-14 Ouro Fino Participacoes E Empreendimentos Sa composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia
BRPI0818702A2 (pt) * 2007-10-26 2015-04-22 Rexahn Pharmaceuticals Inc Formulação farmacêutica de ácido clavulânico
US20090170954A1 (en) * 2007-12-14 2009-07-02 Schering-Plough Ltd. Process for Recovering Florfenicol and Florfenicol Analogs
TW201010708A (en) * 2008-06-02 2010-03-16 Intervet Int Bv Composition comprising an antibiotic and a corticosteroid
US8318817B2 (en) * 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
MX2011011459A (es) * 2009-04-29 2011-11-18 Rexahn Pharmaceuticals Inc Formulacion de clavulanato para neuroproteccion y tratamiento de trastornos neurodegenerativos.
RU2424801C1 (ru) * 2010-04-27 2011-07-27 Владимир Васильевич Агеев Средство для лечения инфекционных болезней
ES2893444T3 (es) * 2010-06-29 2022-02-09 Merck Sharp & Dohme Formulaciones de posaconazol en solución intravenosa estabilizadas mediante beta-ciclodextrina sustituida
EP2654500B1 (en) 2010-12-20 2017-07-19 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier
WO2013081044A1 (ja) * 2011-11-30 2013-06-06 富山化学工業株式会社 １－シクロプロピル－８－（ジフルオロメトキシ）－７－［（１ｒ）－１－メチル－２，３－ジヒドロ－１ｈ－イソインドール－５－イル］－４－オキソ－１，４－ジヒドロキノリン－３－カルボン酸のメタンスルホン酸塩水和物含有錠剤
WO2014108872A1 (en) * 2013-01-14 2014-07-17 Wockhardt Limited Compositions and methods for treating bacterial infections
KR101473979B1 (ko) * 2013-01-18 2014-12-26 한국썸벧(주) 마보플록사신을 포함하는 약제학적 조성물
US9078853B2 (en) 2013-06-18 2015-07-14 Cmpd Licensing, Llc Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders
CN104606141A (zh) * 2013-11-01 2015-05-13 瑞普（天津）生物药业有限公司 一种替米考星肠溶微丸
CN104983718A (zh) * 2015-07-17 2015-10-21 江西博莱大药厂有限公司 一种替米考星缓释微丸及其制备方法和应用
CN105412123B (zh) * 2015-11-06 2018-03-13 山东省千佛山医院 布地奈德联合三唑类抗真菌药物的应用及其产品
WO2017091168A1 (en) 2015-11-28 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. A topical spray comprising isoconazole nitrate and difluocortolone valerate
US10966946B2 (en) 2016-11-17 2021-04-06 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
US11737975B2 (en) 2016-11-17 2023-08-29 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
US9999604B2 (en) 2016-11-17 2018-06-19 Cmpd Licensing, Llc Compounded solutions of diclofenac and lidocaine and methods
US10525025B2 (en) 2016-11-17 2020-01-07 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
US11986448B2 (en) 2016-11-17 2024-05-21 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
CN109096307A (zh) * 2017-06-20 2018-12-28 赵建宇 一种33/4水头孢曲松钠化合物
US11534438B2 (en) * 2017-12-25 2022-12-27 Xiangbei Welman Pharmaceutical Co., Ltd. Composition containing piperacillin, pharmaceutical formulation thereof and use thereof
EP4041153A4 (en) * 2019-10-11 2023-10-25 Piedmont Animal Health Inc. OTIC FORMULATIONS, METHODS AND DEVICES
CN111166719A (zh) * 2019-12-31 2020-05-19 郑州都灵兽药科技有限公司 一种泰拉霉素肠溶颗粒的制备方法
CN112089695A (zh) * 2020-10-30 2020-12-18 康普药业股份有限公司 一种头孢克肟颗粒制剂及其制备方法
CN118434420A (zh) 2021-12-20 2024-08-02 英特维特国际股份有限公司 用于治疗耳感染的药物组合物

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141078A (en) 1975-10-14 1979-02-20 Innovated Systems, Inc. Library circulation control system
US4235892A (en) 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
ES488154A0 (es) 1979-02-05 1981-04-16 Schering Corp Un procedimiento para la preparacion de un compuesto d-(treo-1-aril-2-acilamido-3-fluor-1-propanol
NZ199808A (en) 1981-03-03 1986-06-11 Maciver K J A & Sons Machine for renting video tape cassettes:individual compartment for each cassette
US4820695A (en) 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
US4443430A (en) 1982-11-16 1984-04-17 Ethicon, Inc. Synthetic absorbable hemostatic agent
US5105009A (en) 1983-06-02 1992-04-14 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
IT1173213B (it) 1984-02-03 1987-06-18 Zambon Spa Procedimento per fluorurare alcuni derivati dall'1l-fenil-2-ammino-1,3-propandiolo e loro intermedi
US5332835A (en) 1984-02-03 1994-07-26 Zambon S.P.A. Process for fluorinating 1-phenyl-2-amino-1,3-propanediol compounds and new oxazoline compounds useful in this process
US4582918A (en) 1984-09-19 1986-04-15 Schering Corporation Preparation of intermediates for (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
US4973750A (en) 1984-09-19 1990-11-27 Schering Corporation Preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
US4812629A (en) 1985-03-06 1989-03-14 Term-Tronics, Incorporated Method and apparatus for vending
US5104868A (en) 1988-06-21 1992-04-14 Pfizer Inc. Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters
US5095195A (en) 1988-08-03 1992-03-10 Thru-The-Wall Corporation Automated videocassette dispensing terminal with reservation feature
US5594228A (en) 1988-08-25 1997-01-14 Symbol Technologies, Inc. Self-checkout, point-of-transaction system including deactivatable electro-optically coded surveillance tags
US5227494A (en) 1988-09-14 1993-07-13 Schering Corporation Process for preparing oxazoline compounds
US4876352A (en) 1988-09-14 1989-10-24 Schering Corporation Pressurized fluorination of hydroxy alkyl groups
US5491139A (en) 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
CA2001203C (en) 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5007518A (en) 1989-02-13 1991-04-16 Sam Crivello Apparatus for renting articles
US5198220A (en) 1989-11-17 1993-03-30 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
SG47533A1 (en) 1990-04-18 1998-04-17 Procter & Gamble Pharma Antimicrobial quinolonyl lactams
CZ286239B6 (cs) 1990-10-25 2000-02-16 Schering Corporation Způsob přípravy florfenikolu, jeho analogy a oxazolinové meziprodukty
US5242910A (en) 1992-10-13 1993-09-07 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5646163A (en) 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
US5352832A (en) 1992-12-18 1994-10-04 Schering Corporation Asymmetric process for preparing florfenicol, thiamphenicol chloramphenicol and oxazoline intermediates
KR0148277B1 (ko) 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
WO1994025464A1 (en) 1993-04-24 1994-11-10 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
CN1041202C (zh) 1993-08-13 1998-12-16 同和药品工业株式会社 一种具有药物活性的喹诺酮羧酸衍生物
FR2711524B1 (fr) 1993-10-21 1995-11-24 Rhone Dpc Europ Procédé de préparation de compositions orales contenant des quinolones.
CA2175804C (en) 1993-11-04 2003-02-25 Peter Y. Zhou Method and apparatus for automatically desensitizing sensor elements
TW377349B (en) * 1993-12-21 1999-12-21 Schering Corp Tetrahydrofuran antifungals
US5661151A (en) * 1993-12-21 1997-08-26 Schering Corporation Tetrahydrofuran antifungals
FI972103A7 (fi) 1994-11-18 1997-05-16 Upjohn Co Fluorokinolonin uusi fysikaalisesti stabiili kiinteä muoto
US5777884A (en) 1995-10-16 1998-07-07 Minnesota Mining And Manufacturing Company Article inventory tracking and control system
US5834472A (en) 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5846971A (en) 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
US5663361A (en) 1996-08-19 1997-09-02 Schering Corporation Process for preparing intermediates to florfenicol
US5990794A (en) * 1996-09-26 1999-11-23 Sensormatic Electronics Corporation Apparatus for data communication and deactivation of electronic article surveillance tags
JP3892085B2 (ja) 1996-10-04 2007-03-14 東興薬品工業株式会社 動物用点耳クリーム剤
US6025780A (en) 1997-07-25 2000-02-15 Checkpoint Systems, Inc. RFID tags which are virtually activated and/or deactivated and apparatus and methods of using same in an electronic security system
PL340606A1 (en) * 1997-10-22 2001-02-12 Jens Ponikau Methods of and materials for treating and preventing mucositis
US6232870B1 (en) * 1998-08-14 2001-05-15 3M Innovative Properties Company Applications for radio frequency identification systems
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US6169483B1 (en) 1999-05-04 2001-01-02 Sensormatic Electronics Corporation Self-checkout/self-check-in RFID and electronics article surveillance system
US6333692B1 (en) 1999-07-06 2001-12-25 Ats Money Systems Inc. Security tag deactivation system
US20020067267A1 (en) * 2000-03-15 2002-06-06 Richard Kirkham Package identification system
CN1137899C (zh) 2000-03-16 2004-02-11 上海华联制药有限公司 17,21-酯取代的1,4-二烯-3-酮-9,11-环氧甾体化合物
AU2001261748A1 (en) 2000-05-19 2001-12-03 Alcon Laboratories Inc. Antibiotic compositions for treatment of the eye, ear and nose
US20020037877A1 (en) * 2000-07-26 2002-03-28 Alcon Universal Ltd. Pharmaceutical suspension compositions lacking a polymeric suspending agent
EP1383780A1 (en) 2001-04-27 2004-01-28 Pfizer Products Inc. Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
AU2002333671B2 (en) * 2001-09-21 2006-07-20 Novartis Ag Method of treating middle ear infections
CN1688306A (zh) 2002-09-23 2005-10-26 先灵公司 泊沙康唑用于治疗真菌感染的用途
US20050159369A1 (en) * 2003-08-20 2005-07-21 Qtm Llc Method of treatment of otitis externa
RU2394573C2 (ru) 2004-08-13 2010-07-20 Шеринг-Плоу Лтд. Фармацевтическая композиция
TW201010708A (en) 2008-06-02 2010-03-16 Intervet Int Bv Composition comprising an antibiotic and a corticosteroid

Also Published As

Publication number Publication date
WO2006020689A1 (en) 2006-02-23
NO20073073L (no) 2007-06-15
AU2005272925B2 (en) 2011-02-10
TW200621238A (en) 2006-07-01
CN102499928A (zh) 2012-06-20
NZ553119A (en) 2010-11-26
KR101289115B1 (ko) 2013-07-23
IL181248A (en) 2014-07-31
AU2005272925A1 (en) 2006-02-23
ZA200701253B (en) 2008-07-30
BRPI0514098A (pt) 2008-05-27
AR050838A1 (es) 2006-11-29
DE602005012107D1 (de) 2009-02-12
US8084445B2 (en) 2011-12-27
US20120058964A1 (en) 2012-03-08
MX2007001811A (es) 2007-03-26
KR20070041571A (ko) 2007-04-18
HK1098368A1 (en) 2007-07-20
UA89793C2 (uk) 2010-03-10
ECSP077239A (es) 2007-03-29
RU2007108875A (ru) 2008-09-20
US8609645B2 (en) 2013-12-17
MY145148A (en) 2011-12-30
US20060122159A1 (en) 2006-06-08
CN101039668A (zh) 2007-09-19
EP1776109A1 (en) 2007-04-25
IL181248A0 (en) 2007-07-04
BRPI0514098B1 (pt) 2021-01-19
PT1776109E (pt) 2009-03-25
ES2320360T3 (es) 2009-05-21
TWI362261B (en) 2012-04-21
JP2011178811A (ja) 2011-09-15
CA2576589A1 (en) 2006-02-23
JP2008509913A (ja) 2008-04-03
CA2576589C (en) 2013-11-12
PE20060489A1 (es) 2006-06-19
EP1776109B1 (en) 2008-12-31
JP4792032B2 (ja) 2011-10-12
PL1776109T3 (pl) 2009-06-30
ATE418984T1 (de) 2009-01-15
RU2394573C2 (ru) 2010-07-20

Similar Documents

Publication Publication Date Title
DK1776109T3 (da) Farmaceutisk formulering omfattende et antibiotikum, en triazol og et cortocosteroid
DE60327646D1 (de) Deferasirox dispergierbare tablette
DK2298288T4 (da) Overtrukket tabletformulering og fremgangsmåde
DK1545662T3 (da) Lægemiddelindgivelsessystem
NO20052855D0 (no) Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
NO20054534D0 (no) Leveringssystem for legemiddel og celleterapi
EP1620118A4 (en) REVERSIBLE PEGYLATED MEDICAMENTS
DK1575618T3 (da) Dispergerbare farmaceutiske kombinationer
IL172620A0 (en) Intravaginal drug delivery devices
PL379425A1 (pl) Wielowarstwowa tabletka dyspergowalna w ustach
PL374347A1 (en) Solid pharmaceutical formulations comprising telmisartan
ATE388693T1 (de) Wohlschmeckende kautablette
GB0316206D0 (en) Pharmaceutical formulation
AU2003293051A1 (en) Multichannel and multilayer pharmaceutical device
DE50304722D1 (de) Fungizide Wirkstoffkombinationen
GB0308968D0 (en) Medicaments
GB0314733D0 (en) Medicaments
GB2401043B (en) Drug
DK1791872T3 (da) Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf
GB0406048D0 (en) Drug formulations
PL355453A1 (en) Pharmaceutical agent
GB0316671D0 (en) Active verify
AU2003238590A1 (en) Tablets comprising ciprofloxacin hydrochloride
DE112004001429D2 (de) Pharmazeutischer Wirkstoff
EP1624073A4 (en) DRUG